|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2005-9-21
|
|
pubmed:abstractText |
Few clinical trials have investigated the use of lamivudine (LAM) in patients with decompensated cirrhosis related to chronic hepatitis B. The aim of the present study was to evaluate the efficacy of extended LAM treatment and to determine the timing of LAM administration in patients with decompensated cirrhosis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Oct
|
|
pubmed:issn |
0815-9319
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
20
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1527-32
|
|
pubmed:dateRevised |
2008-11-21
|
|
pubmed:meshHeading |
pubmed-meshheading:16174069-Adult,
pubmed-meshheading:16174069-DNA, Viral,
pubmed-meshheading:16174069-Drug Administration Schedule,
pubmed-meshheading:16174069-Female,
pubmed-meshheading:16174069-Follow-Up Studies,
pubmed-meshheading:16174069-Genetic Variation,
pubmed-meshheading:16174069-Hepatitis B,
pubmed-meshheading:16174069-Hepatitis B virus,
pubmed-meshheading:16174069-Humans,
pubmed-meshheading:16174069-Lamivudine,
pubmed-meshheading:16174069-Liver Cirrhosis,
pubmed-meshheading:16174069-Male,
pubmed-meshheading:16174069-Middle Aged,
pubmed-meshheading:16174069-Reverse Transcriptase Inhibitors,
pubmed-meshheading:16174069-Severity of Illness Index,
pubmed-meshheading:16174069-Treatment Outcome
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Timing of lamivudine administration according to Child class in patients with decompensated cirrhosis.
|
|
pubmed:affiliation |
Department of Internal Medicine, Kangnam St. Mary's Hospital, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
